The Promise of Personalized Medicine | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Personalized Medicine in NSCLC

Gene Sequencing – to the Bedside »

The Promise of Personalized Medicine

March 3, 2013 by larryhbern

The Promise of Personalized Medicine

Reporter: Larry H Bernstein, MD, FCAP

Realizing the Promise of Personalized Medicine

Harvard Business Review

MG Aspinal, RG Hamermesh

Obsolete business models, regulations, reimbursement systems, and physicians stand in the way

http://missionfacilitators.com/Articles/Organizational-development/Articles/realizing-the-promise-of-personalized-medicine.pdf/

NewYear for Angels

NewYear for Angels (Photo credit: Wikipedia)

BusinessModel

BusinessModel (Photo credit: Wikipedia)

Harvard Business Review and Fifth Global Peter Drucker Forum Form Partnership (prweb.com)
Is Your Company Ready for the Circular Economy? – Eric Hellweg – Harvard Business Review (entrepreneurshipmatters.com)
Kaggle Visualization Contest yields insights on influence at Harvard Business Review, by @stephanieoverby (nextlevelofnews.com)
Attitudes of Patients about Personalized Medicine (pharmaceuticalintelligence.com)
ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

Posted in FDA Regulatory Affairs, Genome Biology, Genomic Testing: Methodology for Diagnosis, Health Economics and Outcomes Research, Health Law & Patient Safety, Molecular Genetics & Pharmaceutical, Nanotechnology for Drug Delivery, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Population Health Management, Genetics & Pharmaceutical, Regulated Clinical Trials: Design, Methods, Components and IRB related issues, Technology Transfer: Biotech and Pharmaceutical | Tagged Business, Business model, Education, Harvard Business Review, Harvard Business School, Harvard University, Larry H. Bernstein, Massachusetts, United States | 1 Comment

One Response

on March 27, 2013 at 7:00 PM | Reply Genomic Liberty of Ownership, Genome Medicine and Patenting the Human Genome | Pharmaceutical Intelligence

I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette

Loading...

Leave a ReplyCancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,319 other subscribers
Recent Posts
- The Nobel Prize in Physiology or Medicine 2023 October 2, 2023
- The Current Impact and Future of Technology within Cardiovascular Surgery September 23, 2023
- The Continued Impact and Possibilities of AI in Medical and Pharmaceutical Industry Practices September 18, 2023
- Regulatory T cells (Tregs) are important for sperm tolerance and male fertility September 11, 2023
- ChatGPT Chemistry Assistant for Text Mining and the Prediction of metal–organic framework (MOF) synthesis August 27, 2023
- Eight Subcellular Pathologies driving Chronic Metabolic Diseases – Methods for Mapping Bioelectronic Adjustable Measurements as potential new Therapeutics: Impact on Pharmaceuticals in Use August 19, 2023
- ChatGPT Searches and Advent of Meta Threads: What it Means for Social Media and Science 3.0 July 11, 2023
- OpenAI and ChatGPT face unique legal challenges over CopyRight Laws July 10, 2023
- World Medical Innovation Forum, June 12 – June 14, 2023 The Westin Boston Seaport District organized by Mass General Brigham (MGB) June 25, 2023
- Revolutionizing Business with Apple Vision Pro: The Ultimate Tool for Enhanced Visual Communication June 22, 2023
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: